AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
15 hedge funds and large institutions have $165M invested in Ambrx Biopharma, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 7 closing their positions.
Holders
15
Holders Change
-5
Holders Change %
-25%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
1
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
Fidelity Investments
Boston,
Massachusetts
|
$50.3M |
2 |
2
Morgan Stanley
New York
|
$38K |
3 |
MIFH
3
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
$3K |